The global drug and gene delivery devices market size is expected to reach USD 1.22 billion by 2030, registering a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising investment by the market players to develop innovative drug delivery systems to cater to the demand by the patients as well as to increase the bioavailability at minimum quantity of active pharmaceutical ingredient is driving the market growth. Additionally, increasing focus on R&D of gene delivery systems owing to the high growth potential of gene therapy for the treatment of a wide range of diseases is expected to fuel the market growth in the future.
Drug delivery systems are in a constant evolution along with the changing preference by the patient. For instance, initially, hormone replacement therapy was widely prescribed in the form of pills, whereas, it is now available in the form of prefilled syringes, patches, vaginal rings, gel, and sprays. The principal purpose of development of different forms of delivery systems is to increase the ease of use. Factors such as aesthetics of the delivery systems, price, and amount of API are also considered while designing the drug delivery system.
Access the Drug And Gene Delivery Devices Market Size, Share & Trends Analysis Report By Route Of Administration (Oral, Inhalation, Transdermal), By Vector (Viral, Non-Viral), By Region, And Segment Forecasts, 2024 - 2030
Drug And Gene Delivery Devices Market Report Highlights
· In 2023, the oral segment dominated the market and accounted for the largest revenue share of 52.7%, owing to its convenience and ease of administration.
· The injectable segment is expected to witness the fastest CAGR of 11.0% during the forecast period, fueled by increasing prevalence of life-threatening diseases and advancement in injectable drug delivery devices.
· In 2023, North America dominated the drug and gene delivery devices market with a revenue share of 54.0%, owing to the rising number of people suffering from chronic diseases.
· The drug and gene delivery devices market in Asia Pacific is projected to witness growth during the forecast period. The growth can be attributed to the increasing prevalence of chronic diseases such as heart disease, diabetes and cancer owing to the changing lifestyle, increase in consumption of alcohols and cigarettes.
Key Drug And Gene Delivery Devices Company Insights
Some of the key companies in the drug and gene delivery devices market include, Uniqure N.V.; Shanghai Sunway Biotech Co., Ltd; Pfizer, Inc.; Johnson and Johnson.
UniQure NV develops adeno-associated virus (AAV) based gene therapies with the help of its gene technology platform and offers treatments to patients suffering with severe genetic disorders.
Epeius Biotechnologies Corporation develops anti-cancer agents that eliminate metastatic disease.
Order your free sample copy of “Drug And Gene Delivery Devices Market Report 2024 - 2030, published by Grand View Research
Key Drug And Gene Delivery Devices Companies:
The following are the leading companies in the drug and gene delivery devices market. These companies collectively hold the largest market share and dictate industry trends.
· Uniqure N.V.,
· SiBiono GeneTech Co.
· Epeius Biotechnologies Corporation
· Shanghai Sunway Biotech Co., Ltd
· Pfizer, Inc.
· F. Hoffmann-La Roche Ltd.
· Johnson and Johnson
· Novartis AG
· Bayer AG
· Becton, Dickinson and Company
About Grand View Research:
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies, ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit www.grandviewresearch.com
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Email: [email protected]
